After launching CropConnect in 2013, Mehta and Jhajharia traversed the country, meeting and talking with farmers—70,000 km across 20 states. “The aim was to bridge the gap between farmers and consumers,” explains Mehta. In 2015, they launched Original Indian Table, an e-commerce platform for their products. Today, they have a total of 100 products which includes black rice from Manipur, black peas from Ladakh, and bamboo rice. Jhajharia says that their biggest customers are hotels and restaurants, including Hyatt, ITC, Olive, Bombay Canteen, and Kala Ghoda Café. Revenues have been increasing rapidly, he adds. “Quarter-on-quarter we are seeing revenues growing by about 50% to 100%.” CropConnect is entirely self-funded. Jhajharia says they wanted to establish the business model before approaching funders. “Our cash position is quite comfortable at the moment. But by mid-2017, we should start the funding process,” he says.
Top Stories
Enterprise
Puneet J & Ishira Mehta: Bridging the gap between farmers and consumers
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.